A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Exscientia PLC stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 13,371 shares of EXAI stock, worth $64,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,371
Previous 15,825 15.51%
Holding current value
$64,715
Previous $80,000 18.75%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$4.26 - $6.0 $10,454 - $14,724
-2,454 Reduced 15.51%
13,371 $65,000
Q2 2024

Jul 19, 2024

SELL
$3.99 - $6.04 $14,076 - $21,309
-3,528 Reduced 18.23%
15,825 $80,000
Q1 2024

Apr 22, 2024

SELL
$5.3 - $7.51 $68,195 - $96,631
-12,867 Reduced 39.93%
19,353 $110,000
Q4 2023

Jan 16, 2024

BUY
$4.35 - $6.88 $140,157 - $221,673
32,220 New
32,220 $206,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.